Affiliation:
1. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia
Abstract
There is growing evidence showing that prostate cancer cells have perturbed cholesterol homoeostasis, accumulating cholesterol to promote cell growth. Consequently, cholesterol-lowering drugs such as statins are being evaluated in prostate cancer treatment. Furthermore, natural products such as betulin (from birch tree bark) and tocotrienol (a minor form of vitamin E) have been shown to lower cholesterol levels. Using these drugs and oxysterols, we have determined which aspects of cholesterol homoeostasis should be targeted in prostate cancer, e.g. cellular cholesterol levels are increased by the transcription factor SREBP-2 (sterol-regulatory-element-binding protein isoform 2), whereas LXR (liver X receptor) promotes cholesterol efflux. Whereas betulin exerted non-specific effects on cell viability, tocotrienols produced a strong direct correlation between SREBP-2 activity and cell viability. Mechanistically, tocotrienols lowered SREBP-2 activity by degrading mature SREBP-2 independently of the proteasome. In contrast, no correlation was seen between LXR activity and cell viability, implying that SREBP-2 is a better target than LXR for prostate cancer treatment. Lastly, androgen-dependent and -independent LNCaP cells were both sensitive to tocotrienols. Overall, this suggests that tocotrienols and other drugs targeting the SREBP-2 pathway are a potential therapeutic option for prostate cancer.
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference57 articles.
1. Global cancer statistics;Jemal;Ca Cancer J. Clin.,2011
2. Cholesterol, statins and cancer;Brown;Clin. Exp. Pharmacol. Physiol.,2007
3. Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol;Solomon;Metab.,2008
4. Prostatic cholesterol metabolism: regulation and alteration;Schaffner;Prog. Clin. Biol. Res.,1981
5. The Akt–SREBP nexus: cell signaling meets lipid metabolism;Krycer;Trends Endocrinol. Metab.,2010
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献